83 Followers on Owler
KALA BIO is a Massachusetts-based biopharmaceutical company that researches and develops novel therapies for the treatment of retinal diseases... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights
KALA BIO is a Massachusetts-based biopharmaceutical company that researches and develops novel therapies for the treatment of retinal diseases... Read more
Kala Bio Interim-CEO: Todd Bazemore

Interim-CEO

Todd Bazemore

CEO Approval Rating

- -/100

2009

PublicIndependent CompanyNASDAQKALA

Pharmaceuticals & Biotechnology
PharmaceuticalsBiotechnology
28342836 NAICS listing

Annual Revenue
$3.9M
Employees
30
Funding
$529.1M
Acquisitions
1

News

Conference Presentation
Feb 26, 2025
Marketscreener
KALA BIO to Present at TD Cowen 45th Annual Health Care Conference
Leadership Change
Feb 12, 2025
GlobalNewswire
Todd Bazemore joined KALA BIO as Interim-CEO
Funding
Jun 29, 2024
SEC
Kala received $12.5M in Post-IPO Equity Funding

Kala Bio Competitors

1Kiora
2Amber Ophthalmics
3ReGenTree
4Recordati
5Claris Bio
6RHEACELL
7Chiesi
8Moderna
9Gyroscope
10Arena
Unlock 12 + competitors

Trending Companies